# IMIPENEM AND CILASTATIN
> **ANDA207594** · Abbreviated New Drug Application (Generic) · Sponsor: HQ SPCLT PHARMA · Approved 2019-12-12
## Drug
- **FDA Application Number:** ANDA207594
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IMIPENEM AND CILASTATIN
- **Generic name:** IMIPENEM AND CILASTATIN
- **Active ingredients:** CILASTATIN SODIUM; IMIPENEM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HQ SPCLT PHARMA
- **Manufacturer:** WG Critical Care, LLC
- **First approval:** 2019-12-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207594)
---
*MORVS · CC0 1.0*